Global CAR T-Cell Therapy Market Size, Forecast 2023 – 2033
The Global CAR T-Cell Therapy Market Size is Anticipated to Exceed USD 21.92 Billion by 2033, Growing at a CAGR of 17.72% from 2023 to 2033. The use of T cells, which are immune cells, that have undergone genetic modification in a lab to enhance their capacity to identify and eradicate cancer cells, is known as chimeric antigen receptor (CAR) T-cell therapy.